Concentration and avidity of antibodies to different circumsporozoite epitopes correlate with RTS,S/AS01E malaria vaccine efficacy
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Concentration and avidity of antibodies to different circumsporozoite epitopes correlate with RTS,S/AS01E malaria vaccine efficacy
Authors
Keywords
-
Journal
Nature Communications
Volume 10, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-05-15
DOI
10.1038/s41467-019-10195-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Baseline exposure, antibody subclass, and hepatitis B response differentially affect malaria protective immunity following RTS,S/AS01E vaccination in African children
- (2018) Itziar Ubillos et al. BMC Medicine
- Rare PfCSP C-terminal antibodies induced by live sporozoite vaccination are ineffective against malaria infection
- (2017) Stephen W. Scally et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Efficacy of phase 3 trial of RTS, S/AS01 malaria vaccine: The need for an alternative development plan
- (2017) Shima Mahmoudi et al. Human Vaccines & Immunotherapeutics
- Fractional Third and Fourth Dose of RTS,S/AS01 Malaria Candidate Vaccine: A Phase 2a Controlled Human Malaria Parasite Infection and Immunogenicity Study
- (2016) Jason A. Regules et al. JOURNAL OF INFECTIOUS DISEASES
- The biological function of antibodies induced by the RTS,S/AS01 malaria vaccine candidate is determined by their fine specificity
- (2016) Sidhartha Chaudhury et al. MALARIA JOURNAL
- Seven-Year Efficacy of RTS,S/AS01 Malaria Vaccine among Young African Children
- (2016) Ally Olotu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immunogenicity of the RTS,S/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trial
- (2015) Michael T White et al. LANCET INFECTIOUS DISEASES
- The effect of immunization schedule with the malaria vaccine candidate RTS,S/AS01E on protective efficacy and anti-circumsporozoite protein antibody avidity in African infants
- (2015) Anthony Ajua et al. MALARIA JOURNAL
- Genetic Diversity and Protective Efficacy of the RTS,S/AS01 Malaria Vaccine
- (2015) Daniel E. Neafsey et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ad35.CS.01 - RTS,S/AS01 Heterologous Prime Boost Vaccine Efficacy against Sporozoite Challenge in Healthy Malaria-Naïve Adults
- (2015) Christian F. Ockenhouse et al. PLoS One
- RTS,S: Toward a first landmark on the Malaria Vaccine Technology Roadmap
- (2015) David C. Kaslow et al. VACCINE
- A combined analysis of immunogenicity, antibody kinetics and vaccine efficacy from phase 2 trials of the RTS,S malaria vaccine
- (2014) Michael T White et al. BMC Medicine
- Avidity of Anti-Circumsporozoite Antibodies following Vaccination with RTS,S/AS01E in Young Children
- (2014) Ally Olotu et al. PLoS One
- Duration of vaccine efficacy against malaria: 5th year of follow-up in children vaccinated with RTS,S/AS02 in Mozambique
- (2014) Joseph J. Campo et al. VACCINE
- Efficacy and Safety of the RTS,S/AS01 Malaria Vaccine during 18 Months after Vaccination: A Phase 3 Randomized, Controlled Trial in Children and Young Infants at 11 African Sites
- (2014) PLOS MEDICINE
- Four-Year Efficacy of RTS,S/AS01E and Its Interaction with Malaria Exposure
- (2013) Ally Olotu et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Relationship between RTS,S Vaccine-Induced Antibodies, CD4+ T Cell Responses and Protection against Plasmodium falciparum Infection
- (2013) Michael T. White et al. PLoS One
- A Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African Infants
- (2012) NEW ENGLAND JOURNAL OF MEDICINE
- Unexpected fold in the circumsporozoite protein target of malaria vaccines
- (2012) M. B. Doud et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Efficacy of RTS,S/AS01E malaria vaccine and exploratory analysis on anti-circumsporozoite antibody titres and protection in children aged 5–17 months in Kenya and Tanzania: a randomised controlled trial
- (2011) Ally Olotu et al. LANCET INFECTIOUS DISEASES
- First Results of Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African Children
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- Long‐Term Safety and Efficacy of the RTS,S/AS02A Malaria Vaccine in Mozambican Children
- (2009) Jahit Sacarlal et al. JOURNAL OF INFECTIOUS DISEASES
- Randomized, Double‐Blind, Phase 2a Trial of Falciparum Malaria Vaccines RTS,S/AS01B and RTS,S/AS02A in Malaria‐Naive Adults: Safety, Efficacy, and Immunologic Associates of Protection
- (2009) Kent E. Kester et al. JOURNAL OF INFECTIOUS DISEASES
- Insights into Long-Lasting Protection Induced by RTS,S/AS02A Malaria Vaccine: Further Results from a Phase IIb Trial in Mozambican Children
- (2009) Caterina Guinovart et al. PLoS One
- Efficacy of RTS,S/AS01E Vaccine against Malaria in Children 5 to 17 Months of Age
- (2008) Philip Bejon et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started